Gene · 57007
Papers3,960
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,960
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Constructing a chemokine-based model and identifying CCL17 as a core biomarker associated with immune infiltrates in thyroid cancer. | Transl Cancer Res | 2025 | 41158211 | PubTator, text mining | PubMed |
| Cytokine and Chemokine-Associated Signatures Underlying Dermal Invasion and Skin Metastasis in Melanoma. | Int J Mol Sci | 2025 | 41096602 | PubTator, text mining | PubMed |
| Hijacking Extracellular Targeted Protein Degrader-Drug Conjugates for Enhanced Drug Delivery. | J Am Chem Soc | 2025 | 41091621 | PubTator, text mining | PubMed |
| Binding and ubiquitination-mediated degradation of ACKR3 by the novel Scutellarein derivative TBS6b potently suppresses hepatocellular carcinoma. | Bioorg Chem | 2025 | 41075613 | PubTator, text mining | PubMed |
| C-X-C chemokine receptor family genes in osteosarcoma: expression profiles, regulatory networks, and functional impact on tumor progression. | Hereditas | 2025 | 41024311 | PubTator, text mining | PubMed |
| Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer. | Cells | 2025 | 41002447 | PubTator, text mining | PubMed |
| Complex Genetics and Regulatory Drivers of Hypermobile Ehlers-Danlos Syndrome: Insights from Genome-Wide Association Study Meta-analysis. | medRxiv | 2025 | 41001447 | PubTator, text mining | PubMed |
| Implications of canonical histone H3.1 and histone variant H3.3 in cancer. | Open Biol | 2025 | 40987316 | PubTator, text mining | PubMed |
| Chemokine-receptor-guided B-cell immunity in cardiovascular disease. | Basic Res Cardiol | 2025 | 40986007 | PubTator, text mining | PubMed |
| Distal lung organoids derived from adult stem cells as novel tools in deciphering mechanisms of lung regeneration, infection, and cancer. | Stem Cells Transl Med | 2025 | 40966450 | PubTator, text mining | PubMed |
| A cytokine receptor-targeting chimera (kineTAC) toolbox for expanding extracellular targeted protein degradation. | bioRxiv | 2025 | 40949987 | PubTator, text mining | PubMed |
| Potential of Selected C-X-C Motif Chemokines as Biomarkers in Colorectal Cancer Diagnosis. | Int J Mol Sci | 2025 | 40943634 | PubTator, text mining | PubMed |
| [The Molecular Mechanism of HCQ Reversing Immune Mediators Dysregulation in Severe Infection after Chemotherapy in Acute Myeloid Leukemia and Inducing Programmed Death of Leukemia Cells]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40936112 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. | J Exp Clin Cancer Res | 2025 | 40898244 | PubTator, text mining | PubMed |
| Investigating the interaction of ACKR1 and c-Myc in the breast carcinoma tumor microenvironment modulation. | Discov Oncol | 2025 | 40853589 | PubTator, text mining | PubMed |
| Obesity impact on leukocyte telomere shortening and immune aging assessed by Mendelian randomization and transcriptomics analysis. | Sci Rep | 2025 | 40847086 | PubTator, text mining | PubMed |
| Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer. | Proteomes | 2025 | 40843709 | PubTator, text mining | PubMed |
| Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. | Signal Transduct Target Ther | 2025 | 40841367 | PubTator, text mining | PubMed |
| Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mapping. | Nat Commun | 2025 | 40825773 | PubTator, text mining | PubMed |
| HCQ reverses the immune imbalance related to severe infections following chemotherapy of acute myeloid leukemia and exhibits inhibitory effects on inflammatory cytokine storms. | Clin Exp Med | 2025 | 40815351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57007/papers?page=6